Nabiximols for multiple sclerosis.
出版信息
Aust Prescr. 2018 Dec;41(6):203-204. doi: 10.18773/austprescr.2018.066. Epub 2018 Oct 18.
Abstract
摘要
相似文献
1
Nabiximols for multiple sclerosis.用于治疗多发性硬化症的纳布西莫尔
Aust Prescr. 2018 Dec;41(6):203-204. doi: 10.18773/austprescr.2018.066. Epub 2018 Oct 18.
2
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.纳布西莫尔（四氢大麻酚/大麻二酚口腔黏膜喷雾剂，商品名：萨替维克斯）在临床实践中的应用——一项针对多发性硬化症痉挛患者的多中心、非干预性研究（MOVE 2）的结果
Eur Neurol. 2014;71(5-6):271-9. doi: 10.1159/000357427. Epub 2014 Feb 12.
3
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis.难治性三叉神经痛对一名多发性硬化症患者的纳布西莫尔有反应。
Mult Scler Relat Disord. 2016 Jul;8:64-5. doi: 10.1016/j.msard.2016.05.004. Epub 2016 May 2.
4
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).物理治疗干预对使用大麻二酚/四氢大麻酚口溶膜（nabiximols，THC:CBD 或黏膜喷雾）治疗的多发性硬化相关痉挛患者的影响。
PLoS One. 2019 Jul 30;14(7):e0219670. doi: 10.1371/journal.pone.0219670. eCollection 2019.
5
Walking improvements with nabiximols in patients with multiple sclerosis.纳布西莫尔对多发性硬化症患者步行能力的改善作用。
J Neurol. 2015 Nov;262(11):2472-7. doi: 10.1007/s00415-015-7866-5. Epub 2015 Aug 5.
6
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.一项纳比西莫司（Sativex®）作为附加治疗药物，用于治疗多发性硬化症引起的难治性痉挛的随机、双盲、安慰剂对照、平行组、富集设计研究。
Eur J Neurol. 2011 Sep;18(9):1122-31. doi: 10.1111/j.1468-1331.2010.03328.x. Epub 2011 Mar 1.
7
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).一项安慰剂对照、平行分组、随机撤药研究，纳入了正在接受长期 Sativex®（nabiximols）治疗的多发性硬化症所致痉挛症状患者。
Mult Scler. 2012 Feb;18(2):219-28. doi: 10.1177/1352458511419700. Epub 2011 Aug 30.
8
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.纳布啡醇作为大麻戒断期的激动剂替代治疗：一项随机临床试验。
JAMA Psychiatry. 2014 Mar;71(3):281-91. doi: 10.1001/jamapsychiatry.2013.3947.
9
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.在一项意大利单中心真实世界研究中纳布西莫尔（Sativex®）治疗多发性硬化痉挛的疗效与安全性
Neurol Sci. 2016 Feb;37(2):235-42. doi: 10.1007/s10072-015-2392-x. Epub 2015 Oct 16.
10
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.纳比昔单抗治疗多发性硬化症的临床疗效与免疫途径的下调相关。
Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.
引用本文的文献
1
Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases.大麻素类药物治疗胃肠道和肝脏疾病的药理学、临床效果和治疗潜力。
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1748-1758.e2. doi: 10.1016/j.cgh.2020.04.020. Epub 2020 Jul 13.
本文引用的文献
1
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).一项安慰剂对照、平行分组、随机撤药研究，纳入了正在接受长期 Sativex®（nabiximols）治疗的多发性硬化症所致痉挛症状患者。
Mult Scler. 2012 Feb;18(2):219-28. doi: 10.1177/1352458511419700. Epub 2011 Aug 30.
2
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.一项纳比西莫司（Sativex®）作为附加治疗药物，用于治疗多发性硬化症引起的难治性痉挛的随机、双盲、安慰剂对照、平行组、富集设计研究。
Eur J Neurol. 2011 Sep;18(9):1122-31. doi: 10.1111/j.1468-1331.2010.03328.x. Epub 2011 Mar 1.
3
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.一项针对患有多发性硬化症所致痉挛症状患者的Sativex双盲、随机、安慰剂对照、平行组研究。
Neurol Res. 2010 Jun;32(5):451-9. doi: 10.1179/016164109X12590518685660. Epub 2010 Mar 19.
4
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.大麻类药物治疗多发性硬化所致痉挛的随机对照试验。
Eur J Neurol. 2007 Mar;14(3):290-6. doi: 10.1111/j.1468-1331.2006.01639.x.
Zotero 插件